text

AstraZeneca trial joy; Turkey backs EU digital pass: COVID-19 Bulletin

TOP HEADLINES:· A new trial conducted by AstraZenecaof 5,197 participants who had not been exposed to COVID-19showed a 77 percent reduced risk of developing symptomatic disease. The participants were